Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains - Normandie Université Access content directly
Journal Articles Journal of Clinical Virology Year : 2019

Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains

No file

Dates and versions

hal-02155359 , version 1 (13-06-2019)

Identifiers

Cite

V. Avettand-Fenoel, A. Mélard, Marie Gueudin, A. Maillard, J. Dina, et al.. Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains. Journal of Clinical Virology, 2019, 110, pp.36-41. ⟨10.1016/j.jcv.2018.12.002⟩. ⟨hal-02155359⟩
56 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More